General Information of DTT (ID: TT5TOX7)

DTT Name Human immunodeficiency virus Maturation (HIV Mat) DTT Info
Gene Name HIV Mat

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
BMS-955176 DMMEAGO Human immunodeficiency virus-1 infection 1C62 Phase 2 [1]
GSK2838232 DMCIGRW Human immunodeficiency virus-1 infection 1C62 Phase 2 [2]
GSK3640254 DMMOWT9 Human immunodeficiency virus infection 1C62 Phase 2 [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of Bristol-Myers Squibb.
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800037762)
3 Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next-generation HIV-1 maturation inhibitor. Pharmacol Res Perspect. 2020 Dec;8(6):e00671.